Copyright
©The Author(s) 2021.
World J Clin Cases. May 16, 2021; 9(14): 3252-3264
Published online May 16, 2021. doi: 10.12998/wjcc.v9.i14.3252
Published online May 16, 2021. doi: 10.12998/wjcc.v9.i14.3252
Characteristics | Total | RD with AF | RD without AF | P value |
n = 3949203 | n = 944705 (23.9%) | n = 3004498 (76.1%) | ||
Age | < 0.001 | |||
Age, yr, mean ± SD | 67.6 ± 15 | 75.4 ± 10.8 | 65.1 ± 15.3 | |
Gender | < 0.001 | |||
Male | 1811949 (45.9) | 514495 (54.5) | 1297454 (43.2) | |
Female | 2135719 (54.1) | 429900 (45.5) | 1705819 (56.8) | |
Missing-1535 | ||||
Race | < 0.001 | |||
Caucasians | 2675194 (67.7) | 721595 (76.4) | 1953599 (65) | |
African-Americans | 653520 (16.5) | 110355 (11.7) | 543165 (18.1) | |
Others | 620455 (15.7) | 112750 (11.9) | 507705 (16.9) | |
Comorbidities | ||||
Congestive heart failure | 682755(17.3) | 290870 (30.8) | 391885 (13) | < 0.001 |
Coronary arterial disease | 1236959 (31.3) | 444550 (47.1) | 792410 (26.4) | < 0.001 |
Valvular disease | 188325 (4.8) | 73870 (7.8) | 114455 (3.8) | < 0.001 |
Obstructive sleep apnea | 504430 (12.8) | 165060 (17.5) | 339370 (11.3) | < 0.001 |
Chronic pulmonary disease | 954299 (24.2) | 259025 (27.4) | 695275 (23.1) | < 0.001 |
Hypertension | 2536294 (64.2) | 609890 (64.6) | 1926404 (64.1) | < 0.001 |
Diabetes w/o chronic complications | 545765 (13.8) | 129010 (13.7) | 416755 (13.9) | < 0.001 |
Diabetes w/ chronic complications | 676450 (17.1) | 193330 (20.5) | 483120(16.1) | < 0.001 |
Pulmonary Hypertension | 286580 (7.3) | 135975 (14.4) | 150605 (5) | < 0.001 |
Hypothyroidism | 628090 (15.9) | 161685 (17.1) | 466405 (15.5) | < 0.001 |
Renal failure | 1054424 (26.7) | 344655 (36.5) | 709770 (23.6) | < 0.001 |
Obesity | 716165 (18.1) | 166220 (17.6) | 549945 (18.3) | < 0.001 |
Alcohol abuse | 123780 (3.1) | 20585 (2.2) | 103195 (3.4) | < 0.001 |
Drug abuse | 99110 (2.5) | 10800 (1.1) | 88310 (2.9) | < 0.001 |
Outcomes | ||||
In-hospital mortality, Missing-3435 | 94495 (2.4) | 37965 (4) | 56530 (1.9) | < 0.001 |
Adjusted mortality ratio1: 1.46 (1.43-1.48) | ||||
Length of stay, d, mean ± SD | 5.3 ± 5.9 | 6 ± 6.1 | 5.1 ± 5.9 | < 0.001 |
Hospitalization cost, $, mean ± SD | 14419 ± 18731 | 15816 ± 20764 | 13981 ± 18023 | < 0.001 |
Disposition | < 0.001 | |||
Discharge to home | 2051184 (51.9) | 380575 (40.3) | 1670609 (55.6) | |
Transfer (to skilled nursing facility, intermediate-care | 881490 (22.3) | 281705 (29.8) | 599785 (19.9) | |
Home health care | 795225 (20.1) | 214655 (22.7) | 580570 (19.3) | |
Against medical advice | 33465 (0.8) | 4295 (0.5) | 29170 (0.9) | |
Missing-3435 |
- Citation: Khan MZ, Patel K, Patel KA, Doshi R, Shah V, Adalja D, Waqar Z, Franklin S, Gupta N, Gul MH, Jesani S, Kutalek S, Figueredo V. Burden of atrial fibrillation in patients with rheumatic diseases. World J Clin Cases 2021; 9(14): 3252-3264
- URL: https://www.wjgnet.com/2307-8960/full/v9/i14/3252.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i14.3252